Caricamento...
RKIP does not contribute to MAP kinase pathway silencing in the Merkel Cell Carcinoma cell line UISO
BACKGROUND: The Raf kinase inhibitor protein (RKIP) has been shown to block MAP kinase pathway as well as NFκB signalling. By means of immunohistochemistry, we previously demonstrated that the MAP kinase pathway is virtually inactive in Merkel cell carcinoma (MCC). Similarly to MCC in situ high RKIP...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2140056/ https://ncbi.nlm.nih.gov/pubmed/17958888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-3163-6-16 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|